quartr
Japan Lifeline: Net sales rose 8.8% YoY, but operating profit fell 9.4% amid higher R&D and personnel costs
Net sales grew 8.8% year-over-year, led by strong gains in EP/Ablation and Neurovascular, while operating profit declined 9.4% due to higher R&D and personnel costs. The full-year outlook is reaffirmed, and the dividend forecast was raised to ¥81.00 per share, including a commemorative payout.Origi…